DYADIC INTERNATIONAL INC (DYAI)
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
Address
1044 NORTH U.S. HIGHWAY ONE
JUPITER, FL 33477
Founded
1987
Number of Employees
-
Website
http://www.dyadic.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | $10,412 | $2,885 | $3,640 | - | - | - | - | - | - | - | $5,646 |
| Average Price | - | $1.59 | $1.35 | $1.54 | - | - | - | - | - | - | - | $1.53 |
| # Shares Purchased | - | 6,548,473 | 2,136,752 | 2,363,590 | - | - | - | - | - | - | - | 3,682,938 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | -37.1% | -25.9% | -35.1% | - | - | - | - | - | - | - | -34.8% |
| S&P 500 Return to Date | - | 173.0% | 168.6% | 129.7% | - | - | - | - | - | - | - | 157.1% |
| Excess Total Return | - | -210.1% | -194.5% | -164.8% | - | - | - | - | - | - | - | -191.9% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | 20% | 22% | 21% | - | - | - | - | - | - | - | 21% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at DYAI make a trade.
Creating a free account takes less than one minute